does medicaid cover glp-1 Ozempic, Wegovy, and Other Medications? 📢 New Resource Alert! We've

Teede et al

Patients with Cardiovascular Risk Factors: Research suggests that GLP1 receptor agonists may provide cardiovascular benefits, including reduced risk of heart attack and stroke in patients with type 2 diabetes

Ongoing studies explore the potential of CV, renal and neuroprotective benefits of GLP-1RAs and the potential of using GLP-1RAs for other indications, including NASH, neurodegenerative diseases, and T1D

Both medications helped people lose weight and improve other weight-related conditions

Interested in learning more about these weight loss medications

GLP-1 receptor agonists, often referred to simply as GLP-1s, have emerged as a promising option